MedPath

Melatonin and Cognitive-Behaviour Therapy for the treatment of insomnia in individuals with schizophrenia

Phase 4
Conditions
Schizophrenia
Insomnia
Mental Health - Schizophrenia
Public Health - Health service research
Registration Number
ACTRN12613000970741
Lead Sponsor
The University of Western Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
13
Inclusion Criteria

1. Aged 25 to 50 years.
2. A diagnosis of schizophrenia or schizoaffective disorder
3. Length of illness 10-15 years
4. Currently in a clinically stable condition
5. Current insomnia symptoms, characterised by Sleep Onset Latency (SOL) more than 30 minutes, or waking up 3 or more times per night, with an ongoing duration of the sleep problem for at least one month.
6. Stable medication schedule and dosage for the past month
7. English as a first language
8. Using contraceptives (applicable to females only)
9. Confirmation of diagnosis and suitability for the study by the potential participant’s treating psychiatrist
10. Able to provide informed consent

Exclusion Criteria

1. Diagnosis or high indication of sleep-related breathing disorder (e.g. obstructive sleep apnoea), narcolepsy, nightmare disorder, periodic limb movement syndrome, or restless legs syndrome.
2. Suicidality.
3. Allergy to melatonin, corn starch, gelatine
4. BMI >35 (clinical obesity).
5. Co-morbid significant medical conditions (e.g. seizure disorder, traumatic brain injury, dementia, autoimmune disease, liver failure, or kidney failure).
6. Known hereditary problem of galactose intolerance, the LAPP lactase deficiency, or glucose-galactose malabsorption.
7. Pervasive developmental disorder or mental retardation, as defined by DSM-IV or DSM-V criteria.
8. Pregnant or breastfeeding (applicable to females only).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath